Yong Yi

2.5k total citations
68 papers, 2.0k citations indexed

About

Yong Yi is a scholar working on Oncology, Hepatology and Immunology. According to data from OpenAlex, Yong Yi has authored 68 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 22 papers in Hepatology and 20 papers in Immunology. Recurrent topics in Yong Yi's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Yong Yi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Yong Yi collaborates with scholars based in China, Ethiopia and United States. Yong Yi's co-authors include Jia Fan, Jian Zhou, Shuang–Jian Qiu, Jiaxing Wang, Xiaoyan Cai, Shuang‐Jian Qiu, Yi‐Peng Fu, Yunfeng Cheng, Hong-Wei He and Jian Sun and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Yong Yi

67 papers receiving 1.9k citations

Peers

Countries citing papers authored by Yong Yi

Since Specialization

Citations

This map shows the geographic impact of Yong Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Yi more than expected).

Fields of papers citing papers by Yong Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Yi. The network helps show where Yong Yi may publish in the future.

Co-authorship network of co-authors of Yong Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Yi. A scholar is included among the top collaborators of Yong Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Yi. Yong Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of Post-Translational Modifications in Necroptosis 2025 ·Biomolecules ·(unknown), (unknown), Min Xu, Xiangyu Gao, Shuang‐Jian Qiu, Ning Ren, Yong Yi, Chenhao Zhou	1
2	Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis 2024 ·Cancer Medicine ·(unknown), Ruo‐Yu Guan, (unknown), Zhangfu Yang, Bao‐Ye Sun, Jiaxue Wu, Dai Zhang, Guoqiang Sun, (unknown), Jinlong Huang, Gao Liu, Cheng Zhou, Jian Zhou, Jia Fan, Yong Yi, Bo Hu, Shuang–Jian Qiu	1
3	Mobilization and activation of tumor-infiltrating dendritic cells inhibits lymph node metastasis in intrahepatic cholangiocarcinoma 2024 ·Cell Death Discovery ·Bao‐Ye Sun, Zhu-Tao Wang, (unknown), Yang Song, (unknown), (unknown), Guoqiang Sun, Jian Zhou, Jia Fan, Bo Hu, Yong Yi, Shuang–Jian Qiu	10
4	Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy 2024 ·Cancer Research ·Jialei Weng, Zheng Wang, Zhiqiu Hu, (unknown), (unknown), Fu Wang, (unknown), (unknown), Min Xu, Minghao Xu, Dongmei Gao, (unknown), Yong Yi, Yi Shi, Qiongzhu Dong, Chenhao Zhou, Ning Ren	18
5	Peripheral Lymphocytes in Primary Liver Cancers: Elevated NK and CD8+ T Cells and Dysregulated Selenium Metabolism 2024 ·Biomolecules ·Cheng Zhou, (unknown), Bao‐Ye Sun, Yong Yi, Boheng Zhang, Zheng Wang, Shuang‐Jian Qiu	5
6	Sphingosine 1-phosphate receptor 2 promotes the onset and progression of non-alcoholic fatty liver disease-related hepatocellular carcinoma through the PI3K/AKT/mTOR pathway 2023 ·Discover Oncology ·Ganggang Wang, Xin Zhang, (unknown), Chao Song, (unknown), Hao Zhang, (unknown), Yong Yi, (unknown), Ping Zhang, Xinyu Liu, (unknown), Xiaowei Shen, Weixing Shen, Xiaoliang Wang	16
7	Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma 2023 ·Journal for ImmunoTherapy of Cancer ·Jialei Weng, Shaoqing Liu, Qiang Zhou, Wenxin Xu, Minghao Xu, Dongmei Gao, Ying‐Hao Shen, Yong Yi, Yi Shi, Qiongzhu Dong, Chenhao Zhou, Ning Ren	32
8	Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA 2023 ·Hepatology International ·Chenhao Zhou, Jialei Weng, Shaoqing Liu, Qiang Zhou, Zhiqiu Hu, Yirui Yin, Peng Lv, Jialei Sun, Hui Li, Yong Yi, Ying‐Hao Shen, Qing‐Hai Ye, Yi Shi, Qiongzhu Dong, Chunxiao Liu, Xiaoqiang Zhu, (unknown)	3
9	Antiviral therapy improves postoperative survival of patients with HBV-related hepatocellular carcinoma 2022 ·The American Journal of Surgery ·Ruo‐Yu Guan, Bao‐Ye Sun, Zhu-Tao Wang, Cheng Zhou, Zhangfu Yang, Wei Gan, Jinlong Huang, Liu Gao, Jian Zhou, Jia Fan, Yong Yi, Shuang–Jian Qiu	5
10	The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth 2022 ·Cellular Oncology ·Gao Liu, Zhangfu Yang, Jian Sun, Bao‐Ye Sun, Pei‐Yun Zhou, (unknown), Ruo‐Yu Guan, Zhu-Tao Wang, Yong Yi, Shuang‐Jian Qiu	17
11	Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis 2021 ·Cell Death and Disease ·Gao Liu, Jian Sun, Zhangfu Yang, Cheng Zhou, Pei‐Yun Zhou, Ruo‐Yu Guan, Bao‐Ye Sun, Zhu-Tao Wang, Jian Zhou, Jia Fan, Shuang‐Jian Qiu, Yong Yi	95
12	HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1 2019 ·Journal for ImmunoTherapy of Cancer ·Chuyu Jing, Yi‐Peng Fu, Yong Yi, Meixia Zhang, Su-Su Zheng, Jinlong Huang, Wei Gan, Xin Xu, Jiajia Lin, Juan Zhang, Shuang–Jian Qiu, Boheng Zhang	91
13	Serum gamma-glutamyl transferase levels affect the prognosis of patients with intrahepatic cholangiocarcinoma who receive postoperative adjuvant transcatheter arterial chemoembolization: A propensity score matching study 2016 ·International Journal of Surgery ·(unknown), Shuang Liu, Yong Yi, Xiaochun Ni, Jiaxing Wang, Jinlong Huang, Yi‐Peng Fu, Yabing Cao, Jian Zhou, Jia Fan, Shuang–Jian Qiu	14
14	Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection 2016 ·British Journal of Cancer ·Yi‐Peng Fu, Yong Yi, Xiaoyan Cai, Jian Sun, Xiaochun Ni, Hong-Wei He, Jiaxing Wang, (unknown), Jinlong Huang, Yabing Cao, Jian Zhou, Jia Fan, Shuang‐Jian Qiu	63
15	Synergistic effects of progranulin and low intensity pulsed ultrasound on chondrocyte differentiation, migration and metabolism 2015 ·Osteoarthritis and Cartilage ·Sardar M.Z. Uddin, Brendon Richbourgh, Yong Yi, Liu C	2
16	Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection 2014 ·BMC Cancer ·Jiaxing Wang, Yong Yi, Yiwei Li, Xiaoyan Cai, Hong-Wei He, Xiaochun Ni, Jian Zhou, Yunfeng Cheng, Jianjun Jin, Jia Fan, Shuang–Jian Qiu	45
17	High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma 2013 ·Journal of Experimental & Clinical Cancer Research ·Rui Liao, Jian Sun, Han Wu, Yong Yi, Jiaxing Wang, Hong-Wei He, Xiaoyan Cai, Jian Zhou, Yunfeng Cheng, Jia Fan, Shuang‐Jian Qiu	144
18	CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma 2012 ·Cancer Research ·Qiang Gao, Yingjun Zhao, Xiaoying Wang, Shuang–Jian Qiu, Yongyong Shi, Jian Sun, Yong Yi, Jie-Yi Shi, Guo‐Ming Shi, Zhen‐Bin Ding, Yongsheng Xiao, Zhonghua Zhao, Jian Zhou, Xianghuo He, Jia Fan	136
19	B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence 2012 ·Cancer Immunology Immunotherapy ·(unknown), Qiang Gao, Shuang‐Jian Qiu, Jian Zhou, Xiaoying Wang, Yong Yi, Jie-Yi Shi, Yongfeng Xu, Ying‐Hong Shi, Kang Song, Yong‐Sheng Xiao, Jia Fan	90
20	Effects of weightlessness on the apoptosis of hepatocytes in rats. 2010 ·Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi ·Yan Cui, Jiahong Dong, Jinlian Zhou, Ming Zhang, Chenglin Li, (unknown), Yong Yi, Jianzhong Zhang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact